Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.10 USD
Change Today +0.0009 / 0.91%
Volume 2.0M
MJNA On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

medical marijuana inc (MJNA) Snapshot

Open
$0.10
Previous Close
$0.10
Day High
$0.11
Day Low
$0.10
52 Week High
03/27/14 - $0.31
52 Week Low
03/17/15 - $0.09
Market Cap
94.8M
Average Volume 10 Days
3.6M
EPS TTM
--
Shares Outstanding
949.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAL MARIJUANA INC (MJNA)

medical marijuana inc (MJNA) Related Bloomberg News

View More Bloomberg News

medical marijuana inc (MJNA) Related Businessweek News

No Related Businessweek News Found

medical marijuana inc (MJNA) Details

Medical Marijuana, Inc. operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company develops cannabinoid-based health and wellness products, and medical grade cannabinoid compounds; and licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry, as well as offers pre-and-post production tracking, gemplasm references, and packaging and processing services. Its products include Real Scientific Hemp Oil, Cibaderm, Cibdex, and Dixie Botanicals. The company also engages in the management, capitalization, and development of health and wellness facilities, medical clinics, and cooperatives. In addition, it offers cannabidiol based products to consumers; chewing gum-based cannabis/cannabinoid medical products for the treatment of pain and other medical disorders; and cannabidiol hemp oil. Medical Marijuana, Inc. was incorporated in 2003 and is headquartered in San Diego, California.

46 Employees
Last Reported Date: 11/13/14
Founded in 2003

medical marijuana inc (MJNA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medical marijuana inc (MJNA) Key Developments

Medical Marijuana, Inc. Announces Executive and Management Changes

Medical Marijuana, Inc. announced the appointment of cannabis industry veteran and finance expert Dr. Stuart Titus as President and Chief Executive Officer, along with the appointment of four new members of the Board of Directors. In addition to his officer role, Dr. Titus was appointed as a Member of the Board of Directors. Dr. Stuart Titus, Ph.D., is an industry icon and innovator, having been involved in all aspects of the medical marijuana and industrial hemp industries, Dr. Titus was the number seven investor in Medical Marijuana, Inc., having invested in its seed financing. Dr. Titus has been involved in the development and investment of several cannabis and industrial hemp businesses. Dr. Titus is the co-founder and President of General Hemp, LLC which with Titus at the helm has managed the emergence and growth of several other companies, including CannaVest, KannaLife Sciences Inc. (Board Member) and KannaWAY. Dr. Titus' expertise in finance was forged on Wall Street, where he worked as a bond trader for 11 years, managing a trading and underwriting department as a V.P. for CS First Boston Corp. Robert L. Cunningham, Member, Board of Directors: Robert "Bob" Cunningham has over 40 years of executive management experience in financial services and venture capital. He currently is CEO of Preferred Dealer Programs (PDP), a venture-funded partnership with Crosscheck Inc. Prior to joining PDP, Mr. Cunningham was the founding partner in Placer Financial Group. Chris Prine, Member, Board of Directors: Chris Prine has been CEO of Prines Lines since 1994, which acts as a manufacturers' representative for five U.S. furniture-manufacturing companies with distribution worldwide. Mr. Prine has an intrinsic understanding for the world of manufacturing and distribution. From 1988 to 1994, Mr. Prine served as Marketing Director for the Cleator Corporation, an office furniture manufacturer. Dr. Timothy R. Scott, Ph.D. Member, Board of Directors: Dr. Timothy Scott brings years of public and private enterprise board-level management experience. Dr. Scott served on the Board of Directors of NatureWell Incorporated, a publicly traded company engaged in the nutraceutical and homeopathic drug industry from September 2001 to May 2008. From April 1998 to June 2000, Dr. Scott served as a member of the Board of Directors of ICH Corporation and as a member of ICH's compensation committee.

Medical Marijuana, Inc. Reports Revenue Results for the Second Quarter of 2014

Medical Marijuana, Inc. reported revenue results for the second quarter of 2014. For the period, the company reported product sales revenues of $4,821,741 compared to $4,017,774 for the prior quarter.

Medical Marijuana Inc. Announces its Newest Subsidiary, aNew Chocolate, LLC

Medical Marijuana Inc. announced its newest subsidiary, aNew Chocolate, LLC, that manufactures the world's first cannabidiol (CBD)-rich hemp oil-infused chocolate bars. The first aNew Chocolate product will be unveiled at the High Times U.S. Cannabis Cup in Denver, Colorado April 19-20 at the Denver Merchandise Mart located at 451 East 58th Ave. Denver, CO 80216.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJNA:US $0.10 USD +0.0009

MJNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cannabis Science Inc $0.04 USD 0.00
GW Pharmaceuticals PLC 492.75 GBp +1.75
PharmaCyte Biotech Inc $0.15 USD 0.00
View Industry Companies
 

Industry Analysis

MJNA

Industry Average

Valuation MJNA Industry Range
Price/Earnings 19.7x
Price/Sales 6.6x
Price/Book 1.8x
Price/Cash Flow 19.5x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAL MARIJUANA INC, please visit www.medicalmarijuanainc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.